multipl
virus
often
detect
children
respiratori
infect
signific
coinfect
pathogenesi
sever
outcom
unclear
correl
presenc
viral
coinfect
clinic
phenotyp
children
admit
acut
respiratori
infect
ari
collect
detail
clinic
inform
sever
children
admit
ari
part
spanish
prospect
multicent
studi
gendr
network
nest
polymeras
chain
reaction
pcr
approach
use
detect
respiratori
virus
respiratori
secret
find
compar
independ
cohort
collect
uk
result
children
recruit
main
cohort
replic
cohort
number
detect
virus
correl
marker
sever
howev
bacteri
superinfect
associ
increas
sever
pvalu
picu
admiss
pvalu
higher
clinic
score
pvalu
respiratori
introduct
molecular
techniqu
includ
polymeras
chain
reaction
pcr
increas
sensit
detect
common
emerg
respiratori
virus
often
reveal
presenc
one
pathogen
respiratori
patient
import
viral
coinfect
pathogenesi
sever
cours
respiratori
infect
well
establish
high
sensit
molecular
techniqu
rais
question
clinic
relev
posit
test
result
presenc
viru
necessarili
indic
causat
clinic
symptom
diseas
contrari
bacteri
coinfect
usual
associ
sever
diseas
cours
wors
prognosi
despit
precis
interact
bacteria
virus
alway
clear
studi
aim
analyz
relationship
viral
bacteri
coinfect
detect
molecular
method
clinic
phenotyp
children
admit
hospit
lower
tract
acut
respiratori
infect
ltari
two
independ
observ
prospect
patient
group
enrol
spain
main
group
unit
kingdom
replic
group
spanish
children
recruit
januari
januari
nation
hospit
base
research
network
gendr
genet
vitamin
respiratori
infect
research
networkwwwgendr
org
includ
spanish
tertiari
hospit
uk
children
recruit
octob
may
st
mari
hospit
uk
cohort
elig
studi
particip
children
year
age
lower
respiratori
tract
ill
suffici
sever
warrant
admiss
hospit
viru
identifi
nasopharyng
swab
aspir
sampl
type
ltari
includ
bronchiol
pneumonia
without
wheez
fever
rhinorrhea
respiratori
distress
nasopharyng
sampl
aspir
swab
obtain
admiss
viral
pathogen
detect
besid
diagnost
procedur
perform
origin
refer
hospit
viral
detect
perform
recruit
subject
use
panel
virus
nest
pcr
respiratori
syncyti
viru
influenza
viru
b
parainfluenza
viru
type
adenoviru
af
rhinoviru
metapneumoviru
coronaviru
bocaviru
method
previou
describ
et
al
differ
found
molecular
diagnosi
yield
seri
use
aspir
swab
sampl
sourc
micropatholog
ltd
provid
support
form
salari
author
es
cf
addit
role
studi
design
data
collect
analysi
decis
publish
prepar
manuscript
specif
role
author
articul
author
contribut
section
compet
interest
author
follow
interest
edward
sumner
colin
fink
employ
micropatholog
ltd
patent
product
develop
market
product
declar
alter
author
adher
plo
one
polici
share
data
materi
detail
onlin
guid
author
investig
train
studi
protocol
patient
recruit
sampl
process
sampl
storag
studi
perform
accord
good
clinic
practic
written
inform
consent
obtain
parent
legal
guardian
subject
studi
inclus
detail
clinic
data
patient
collect
use
secur
webbas
platform
includ
risk
factor
ltari
prematur
immun
statu
obes
diabet
asthma
previou
admiss
hospit
current
medic
famili
histori
asthma
respiratori
diseas
sever
respiratori
case
rank
follow
physician
criteria
mild
moder
sever
wooddown
scale
point
mild
moder
sever
newli
develop
scale
name
genvip
score
point
assess
food
toler
degre
medic
intervent
need
respiratori
distress
respiratori
frequenc
apnea
malais
fever
see
tabl
detail
scale
supplement
oxygen
mechan
ventil
requir
admiss
also
record
bacteri
superinfect
diagnosi
establish
accord
refer
physician
criteria
base
clinic
data
inflammatori
marker
radiolog
find
andor
appropri
cultur
steril
site
eg
blood
cerebrospin
fluid
studi
purpos
case
classifi
bacteri
coinfect
includ
case
without
microbiolog
confirm
seri
cultur
carri
systemat
bacteri
superinfect
suspect
refer
physician
analysi
compar
clinic
data
result
pathogen
identif
respiratori
sampl
perform
analysi
use
r
softwar
version
wwwrprojectorg
gener
data
present
mean
confid
interv
ci
differ
statist
model
use
assess
bivari
associ
variabl
depend
depend
variabl
relationship
demograph
clinic
variabl
monoinfect
coinfect
analys
use
simpl
logist
regress
binari
logist
model
use
binari
variabl
coinfect
statu
oxygen
requir
respiratori
support
need
picu
admiss
linear
model
continu
variabl
wooddown
score
genvip
score
neg
binomi
regress
model
count
data
hospit
stay
length
logist
multinomi
model
multinomi
variabl
respiratori
distress
statu
multipl
regress
model
consid
use
signific
risk
factor
obtain
bivari
analysi
sex
age
variabl
order
reduc
likelihood
fals
signific
result
due
mani
statist
comparison
bonferroni
multipl
test
correct
consid
test
perform
evalu
correl
bacteri
superinfect
pneumococc
vaccin
level
statist
signific
set
gendr
cohort
includ
nasopharyng
sampl
patient
median
age
ci
month
maletofemal
sex
ratio
one
patient
exclud
due
incomplet
clinic
data
uk
cohort
patient
data
analyz
median
age
ci
month
maletofemal
ratio
fig
comparison
cohort
shown
tabl
pcr
result
precious
describ
et
al
clinic
data
famili
past
medic
histori
need
picu
admiss
hospit
length
stay
oxygen
respiratori
support
need
equival
gendr
uk
cohort
tabl
gendr
cohort
presenc
rhinoviru
copathogen
associ
significantli
increas
wooddown
score
point
ci
pvalu
rsv
infect
associ
increas
oxygen
requir
ci
pvalu
tabl
isol
find
replic
uk
cohort
tabl
find
replic
uk
cohort
fig
tabl
studi
reveal
even
though
multipl
viral
detect
frequent
hospit
children
ltari
associ
relat
either
diseas
sever
clinic
featur
studi
picu
admiss
diseas
sever
accord
differ
scale
need
respiratori
support
length
hospit
stay
follow
similar
pattern
viral
monoversu
coinfect
children
contrariwis
bacteri
superinfect
increas
sever
diseas
cours
pneumococc
vaccin
play
protect
role
detect
multipl
coincid
virus
clinic
set
becom
common
sinc
introduct
molecular
base
multiplex
test
clinic
signific
find
remain
unclear
seem
impact
diseas
sever
increas
diseas
sever
relat
dual
infect
absenc
associ
report
richard
et
al
found
coinfect
children
almost
three
time
like
admit
picu
singl
viral
infect
compar
studi
richard
et
al
develop
retrospect
monocentr
studi
consid
dual
infect
infant
bronchiol
contradictori
evid
link
diseas
sever
specif
respiratori
virus
shorter
hospit
stay
report
children
rhinoviru
bronchiol
rsv
rhinoviru
rsv
coinfect
report
increas
risk
sever
diseas
bronchiol
relaps
studi
find
signific
differ
sever
coinfect
singl
infect
studi
find
increas
sever
ill
children
rsvrhinoviru
dual
infect
seri
rsv
monoinfect
increas
oxygen
requir
rhinoviru
coinfect
pathogen
increas
wooddown
score
spanish
cohort
isol
find
aris
multivari
analysi
could
replic
uk
cohort
sever
studi
report
increas
sever
bocaviru
hbov
coinfect
case
seri
also
agreement
pen
et
al
hbov
commonli
detect
patient
impact
sever
ill
hbov
detect
alongsid
respiratori
virus
establish
pathogen
potenti
possibl
hbov
detect
reflect
asymptomat
persist
prolong
viral
shed
bacteri
superinfect
factor
consist
link
greater
sever
studi
pandem
influenza
indic
respiratori
virus
predispos
bacteri
complic
interact
virus
bacteria
respiratori
infect
extens
report
literatur
underli
mechan
viral
bacteri
synerg
complex
remain
unclear
common
respiratori
viral
infect
influenza
respiratori
syncyti
viru
link
season
increas
streptococcu
pneumonia
diseas
relationship
bacteri
viral
infect
cloud
low
sensit
bacteri
detect
sterilesit
sampl
tradit
cultur
method
relianc
nonspecif
clinic
data
diagnosi
bacteri
coinfect
includ
inflammatori
marker
radiolog
find
appropri
cultur
result
case
gendr
cohort
uk
cohort
bacteri
superinfect
increas
measur
sever
cohort
picu
admiss
respiratori
support
requir
genvip
score
hospit
stay
length
respiratori
distress
interestingli
pneumococc
vaccin
reveal
independ
protect
factor
diseas
sever
patient
pneumococc
vaccin
reduc
sever
viral
ltari
reduct
oxygen
requir
invas
noninvas
ventil
admiss
picu
respiratori
distress
genvip
score
reduc
incid
viral
alveolar
pneumonia
previous
report
pneumococc
vaccin
although
demonstr
reduct
number
confirm
pneumococc
infect
like
reflect
limit
sensit
cultureproven
pneumococc
diseas
pneumonia
protect
effect
pneumococc
vaccin
found
studi
might
reinforc
import
paradigm
viralpenumococci
interact
nasopharynx
level
pathogenesi
clinic
cours
diseas
current
pneumococc
conjug
vaccin
significantli
decreas
nasopharyng
carriag
pneumococci
thu
reduc
possibl
viralpneumococci
direct
interact
one
limit
present
studi
sampl
test
viral
load
quantit
pcr
viral
load
certain
viruseslik
rsvha
associ
coinfect
statu
sever
also
studi
consid
milder
asymptomat
children
addit
bacteri
superinfect
rate
seri
might
overestim
diagnosi
accept
true
even
without
microbiolog
confirm
base
refer
physician
criteria
sever
studi
shown
virus
found
children
respiratori
infect
research
need
understand
natur
histori
respiratori
viral
carriag
infect
howev
find
consist
independ
cohort
differ
make
outcom
robust
summari
sever
cours
acut
respiratori
episod
requir
hospit
children
correl
presenc
one
virus
contrast
bacteri
coinfect
associ
sever
diseas
wherea
pneumococc
vaccin
decreas
sever
futur
studi
need
investig
whether
particular
virus
combin
virus
influenc
risk
bacteri
coinfect
support
inform
fig
flow
chart
studi
popul
main
cohort
gendr
cohort
replic
cohort
ukcohort
jpg
tabl
genvip
score
docx
tabl
demograph
characterist
famili
patient
medic
histori
clinic
cours
princip
viru
children
ari
diseas
sever
consid
respiratori
support
oxygen
requir
characterist
describ
sever
ill
main
cohort
docx
tabl
variabl
analyz
children
ari
diseas
sever
consid
clinic
scale
characterist
describ
sever
ill
main
cohort
docx
tabl
demograph
characterist
famili
patient
medic
histori
clinic
cours
main
viru
children
ari
diseas
sever
gendr
cohort
docx
tabl
children
ari
characterist
moder
sever
respiratori
distress
docx
tabl
comparison
viru
diseas
sever
replic
cohort
uk
cohort
consid
viru
singl
pathogen
coinfect
sampl
docx
tabl
demograph
characterist
clinic
cours
princip
viru
children
ari
diseas
sever
consid
respiratori
support
oxygen
requir
characterist
describ
sever
ill
ukcohort
present
docx
tabl
variabl
analyz
ukcohort
children
diseas
sever
accord
hospit
stay
length
picu
admiss
shown
docx
